Multiple Myeloma Stem Cell Transplant

The standard of care for fit multiple myeloma patients is to receive high dose chemotherapy hdt with autologous stem cell rescue otherwise known as autologous stem cell transplant asct after completion of induction therapy.

Multiple myeloma stem cell transplant. In some cases a bone marrow or stem cell transplant is an option. When stem cell transplants were first developed the new stem cells came from bone marrow and so this was known as a bone marrow. All things considered while the autologous transplant can make the myeloma go away for a period of time even years it does not cure the growth and inevitably the myeloma back. Then the patient receives new healthy blood forming stem cells.

Multiple myeloma patient don kendall had a pretty good idea what to expect when he began his stem cell transplant in january 2014. The transplant of this kind is the standard treatment for patients with various myeloma. Don 64 was able to complete virtually all his treatment as an outpatient and almost. Multiple myeloma isn t considered curable but symptoms wax and wane.

Stem cell transplant for multiple myeloma. It isn t a cure but compared to chemotherapy alone a. Older patients and those with low risk disease show the greatest gains over time while people with high risk factors showed the least change its researchers said. A person with multiple myeloma is likely to have a low blood count.

It can be a strong weapon in your fight against multiple myeloma. In a stem cell transplant the patient gets high dose chemotherapy to kill the cells in the bone marrow. Autologous stem cell transplant can provide significant remission that is both long and deep extending survival. Multiple myeloma survival rate after stem cell transplant.

There can be a long period of dormancy that could. A stem cell transplant replaces diseased stem cells with healthy ones and is often used to treat this form of cancer. A stem cell transplant replaces unhealthy blood cells with healthy ones. The long term survival of people with multiple myeloma following autologous stem cell transplant has steadily improved since 1997 through with the introduction of new medicines a large review study reports.